Abiso, Edna .

HRN: 18-59-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFTAZIDIME 1GM (VIAL)
11/23/2025
11/30/2025
IV
1g
Q8hr
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines